Kader Thiam
Senior Vice President & Chief Scientific Officer, Discovery, Preclinical Models & Services GenOway
Seminars
Thursday 29th January 2026
Advancing Translational Immuno-Oncology: Tumor–Immune Dynamics & Predictive Humanized Models for Immunotherapies
9:30 am
- Highlighting the recruitment dynamics of human immune subsets within the tumor microenvironment in humanized mice
- Harnessing the role of human myeloid and lymphoid cells to investigate tumor biology and therapeutic efficacy
- Showcasing the critical role of myeloid cells in therapy-related immune-related adverse events (IrAEs)
